Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / HSKA - Heska to Host Virtual 2022 Investor Day on May 17 2022


HSKA - Heska to Host Virtual 2022 Investor Day on May 17 2022

PR Newswire

LOVELAND, Colo. , April 29, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, plans to host its 2022 Investor Day in a virtual format on Tuesday, May 17, 2022 at 9:00 a.m. MT / 11:00 a.m. ET . Members of Heska's leadership will provide strategic updates and discuss the Company's key growth drivers.

Company presentations will cover:

  • Heska Position in Global Veterinary Health Market
  • Heska Strategic Plan 2023 – 2027:  Win at Scale and Reinvention
  • The Complete Heska Portfolio:  New Products and Services
  • Heska Sales and Profits:  Multi-Year Financial Targets, Key Metrics and Considerations

A question and answer session with management will follow the prepared remarks and formal presentation.

To access the virtual event, register by visiting: https://heska-investor-day-2022.open-exchange.net/ . The event will be webcast and the presentations will be posted to Heska's investor relations website. A replay will be available for one year. For additional information or questions, please Contact Investor Relations at investorrelations@heska.com or 970-617-8399.

About Heska
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostics, informatics, and specialty healthcare solutions through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production for third-parties, primarily for herd animal health. For more information, please visit www.heska.com .

SOURCE Heska Corporation

Stock Information

Company Name: Heska Corporation
Stock Symbol: HSKA
Market: NASDAQ
Website: heska.com

Menu

HSKA HSKA Quote HSKA Short HSKA News HSKA Articles HSKA Message Board
Get HSKA Alerts

News, Short Squeeze, Breakout and More Instantly...